Advances in Cardiometabolic Research - Basic Science and Clinical Aspects

The Ramanbhai Foundation 4th International Symposium on “Recent Advances in Pharmaceutical Sciences” will be held in India from February 2-5, 2009, with a focus on research in the area of cardiovascular and metabolic diseases such as atherosclerosis, hypertension, heart failure, diabetes and obesity. The 2009 meeting aims to bring together the scientific community from across the world, both from academia and industry, to deliberate upon unmet medical needs, new research initiatives, etc., to combat these global epidemics. Over the past several years, RBF symposium has been recognised as the premier event in this part of the world, and has drawn significant participation by the research community worldwide. Workshop Presymposium Workshop on "Recent Advances in Pharmaceutical Sciences” February 02, 2009 10:00 – 10:10 hrs Inauguration 10:10 – 11:30 hrs “VH IVUS – intra vascular imaging and plaque characterization” by Dr. Angela Richter, Director Clinical Affairs and Education, Volcano Europe SA/NV, Belgium. Demonstration of IVUS Platform And "Vulnerable plaque: the paradigm shift for treatment with new diagnostic modalties" and live "VP/ultrasound presentation” by Dr. Ramtin Agah, Cardiologist, Interventional Cardiology, CA, USA. 11:30 – 11:40 hrs TEA 11:40 - 12:40 hrs “Application of Molecular Biological Databases for Quality Research in Disease and Systems Pathology: Biobase Knowledge Library BioBase” Dr. Olga Kel-Margoulis, BIOBASE GmbH, Vice President Database Curation, Germany. 11:50 – 12:50 hrs Presentation on Illumina platform Dr. Ram Lakshman, Illumina, Singapore 12:50 - 01:30 hrs Demonstration of Illumina microarray platform 01:30 – 02:30 hrs Lunch 02:30 – 03:30 hrs GE Biacore presentation “Review of SPR technology: Focus on description of and theory behind binding analysis and kinetics” 03:30 – 03:50 hrs TEA 03:50 – 05:00 hrs GE Biacore presentation “An Introduction of Concentration analysis and immunogenecity testing on the platform & understanding of small molecules applications”. TECHNICAL PROGRAM Ramanbhai Foundation 4th International Symposium “Advances in Cardiometabolic Research - Basic Science and Clinical Aspects”. February 3-5, 2009 Day 1 : February 3, 2009 09.00 hr Inauguration ceremony 09.05 hr Welcome Shri. Pankaj Patel, Chairman, Zydus Group 09.15 hr Chief-Guest Padma Bhushan Dr. K. K. Talwar, Director PGIMER, Chandigarh 09.35 hr Vote of thanks Dr. Ganesh Nayak, Executive Director, Zydus Cadila Session I Chairpersons * Dr. Jeffrey M. Friedman, Marilyn M. Simpson Professor; Investigator, HHMI, Rockefeller University, USA * Dr. Richard DiMarchi, Linda & Jack Gill Chair in Biomolecular Sciences and Professor of Chemistry, Indiana University 09.40 to 10.15 hrs Keynote address Dr. Roger Newton Co-founder of Esperion Therapeutics, USA [ Co-Discoverer of Lipitor(R) ] 10.15 to 11.00 hrs Coffee break 11.00 to 11.45 hrs Plenary Lecture (PL-1) “Emerging therapeutic strategy for cardiovascular disease – adipocytokines” Dr. Yuji Matsuzawa Director, Sumitomo Hospital, Professor Emeritus, Osaka University, Japan 11.45 to 12.30 hrs Plenary Lecture (PL-2) "Systemic Biomarkers in Atherosclerosis: New Horizons" Dr. John Chapman President Elect, European Atherosclerosis Society Director, Dyslipidemia and Atherosclerosis Research Unit, INSERM, France 12.30 to 13.15 hrs Invited Lecture (IL-1) “Current understanding of the off-target activity of torcetrapib” Dr. Eric Niesor Metabolic & Vascular Disease Area, Roche AG, Switzerland 13.15 to 14.30 hrs Lunch Session II Chairpersons * Dr. Per-Olof Berggren, The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Sweden * Prof. P. Rama Rao, Director, National Institute of Pharmaceutical Education and Research (NIPER), India 14.30 - 15.15 hr Plenary Lecture (PL-3) “Inflammation as a marker and a target to reduce atherosclerosis related cardiovascular events” Prof. François Mach Head of Cardiology Geneva University Hospital, Switzerland 15.15 - 16.00 hr Plenary Lecture (PL-4) “Metabolic Approaches for treatment of ischaemia” Dr. S.C. Manchanda Senior consultant cardiologist, Sir Ganga Ram Hospital, Delhi Formerly Prof. And Head, dept. Of cardiology, AIIMS 16.00 – 17.00 hr Poster presentation and networking 17.00 to 17.45 hr Invited Lecture (IL-2) "Predictive metabolomic, lipomic and transcriptomic profiling of peripheral blood" Dr. Charles Burant Dr. Robert C. and Veronica Atkins Professor of Metabolism, University of Michigan, USA 17.00 to 18.30 hrs Panel discussion Chairperson: Dr. Richard DiMarchi Linda & Jack Gill Chair in Biomolecular Sciences and Professor of Chemistry, Indiana University; Retired Group Vice President, Eli Lilly & Company, USA Dr. Roger Newton Co-founder of Esperion Therapeutics, USA [ Co-Discoverer of Lipitor(R) ] Dr. Yuji Matsuzawa Director, Sumitomo Hospital, Professor Emeritus, Osaka University, Japan Dr. Eric Niesor Metabolic & Vascular Disease Area, F. Hoffmann-La Roche AG Dr. John Chapman President Elect, European Atherosclerosis Society Prof. François Mach Head of CardiologyGeneva University Hospital, Switzerland Dr. S.C. Manchanda Senior consultant cardiologist, Sir Ganga Ram Hospital, Delhi Formerly Prof. And Head, dept. Of cardiology, AIIMS Dr. Charles Burant Dr. Robert C. and Veronica Atkins Professor of Metabolism, University of Michigan, USA Day 2 : February 4, 2009 Session III Chairpersons * Dr. Y. K. Gupta, All India Institute of Medical Sciences (AIIMS), India * Dr. John Chapman, President Elect, European Atherosclerosis Society 09.00 to 9.45 hrs Keynote address "Energy Medicine-a new Vista" Prof. B. M. Hegde MD, FRCP, FRCPE, FRCPG, FRCPI, FACC, FAMS. Retd. Vice Chancellor, Manipal University, India Visiting Prof. Cardiology, The Middlesex Hospital Medical School, University of London, Affiliate Prof. of Human Health, Northern Colorado University, 09.45 to 10.30 hrs Plenary Lecture (PL-5) “Mipomersen: A Novel Lipid Lowering Drug, From the Bench to the Clinic” Dr. Sanjay Bhanot Metabolic Franchise Leader Vice President, Metabolic Diseases Research & Development Isis Pharmaceuticals Inc., USA 10.30 to 11.00 hrs Coffee break 11.00 to 11.45 hrs Invited Lecture (IL-3) “Eprotirome: A novel and physiological approach to CVD risk reduction” Dr. Jens Kristensen, MD, Dr Med Sci, PhD VP Clinical Development Chief Medical Officer Karo Bio AB, Sweden 11.45 to 12.30 hrs Invited Lecture (IL-4) “Targeting Protein Kinase C to treat Ischemia-Reperfusion Damage in the Heart” Dr. Steve Harrison Vice President, Research KAI Pharmaceuticals 12.30 to 13.15 hrs Plenary Lecture (PL-6) "PPARα and β/δ orchestrate hepatic and pancreatic functions" Dr. Walter Wahli Founder Director, Centre for Integrative Genomics, Switzerland 13.15 to 14.30 hrs Lunch Session IV Chairpersons * Dr. N. K. Ganguly, Former Director General, Indian Council of Medical Research (ICMR) * Dr. B.Sesikeran, Director, National Institute of Nutrition, Hyderabad, India 14.30 - 15.15 hr Keynote Address "Leptin and the Homeostatic Control of Energy Balance" Dr. Jeffrey M. Friedman Marilyn M. Simpson Professor; Investigator, HHMI, Rockefeller University, USA 15.15 - 16.00 hr Plenary Lecture (PL-7) “Gut - Brain Communication in the Control of Metabolism” Dr. Matthias H. Tschöp Associate Professor, Departments of Psychiatry and Medicine, Obesity Research Centre/Genome Research Institute, University of Cincinnati, College of Medicine, USA 16.00 – 17.30 hr Coffee Break Poster presentation and networking 17.30 to 18.15 hr Invited Lecture (IL-5) "Stem cell therapy and diabetes" Dr. Anil Bhansali Professor & Head, Endocrinology, Postgraduate Institute of Medical Education & Research, Chandigarh 18.15 to 19.00 hrs Panel discussion Chairperson: Dr. Roger Newton Co-founder of Esperion Therapeutics, USA [ Co-Discoverer of Lipitor(R) ] Prof. B. M. Hegde Retd. Vice Chancellor, Manipal University, India Visiting Prof. Cardiology, The Middlesex Hospital Medical School, University of London. Affiliate Prof. of Human Health, Northern Colorado University, Dr. Sanjay Bhanot Metabolic Franchise Leader, Vice President, Metabolic Diseases Research & Development, Isis Pharmaceuticals Inc., USA Jens Kristensen, MD, Dr Med Sci, PhD. VP Clinical Development, Chief Medical Officer, Karo Bio AB, Sweden Dr. Steve Harrison Vice President, Research, KAI Pharmaceuticals Dr. Walter Wahli Founder Director, Centre for Integrative Genomics, Switzerland Dr. Matthias H. Tschöp Associate Professor, Departments of Psychiatry and Medicine, Obesity Research Centre/Genome Research Institute, University of Cincinnati, College of Medicine, USA Dr. Jeffrey M. Friedman Marilyn M. Simpson Professor; Investigator, HHMI, Rockefeller University, USA Dr. Anil Bhansali Professor & Head, Endocrinology, Postgraduate Institute of Medical Education & Research, Chandigarh 19.00 - 20.00 hr Cultural Program 20.00 - 21.00 hr Dinner Day 3 : February 5, 2009 Session V Chairpersons * Dr. Yuji Matsuzawa Director, Sumitomo Hospital, Professor Emeritus, Osaka University, Japan * Dr. Charles Burant, Dr. Robert C. and Veronica Atkins Professor of Metabolism, University of Michigan, USA 09.00 to 9.45 hrs Keynote address “Molecular mechanisms of antidiabetic effects of estrogen” Dr. Suad Efendic Professor, Karolinska Institutet, Sweden 09.45 to 10.15 hrs Plenary Lecture (PL-8) "SGLT2 Inhibition: A Novel Approach to the Treatment of Type 2 Diabetes" Dr. Jean Whaley Director, Diabetes Drug Discovery Bristol-Myers Squibb, USA 10.15 to 10.45 hrs Coffee break 10.45 to 11.30 hrs Invited Lecture (IL-6) Dr. R. K. Goyal Vice Chancellor, MS University, Baroda, India 11.30 to 12.15 hrs Plenary Lecture (PL-9) “Signal-Transduction in the Endocrine Pancreas” Dr. Per-Olof Berggren The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Sweden 12.15 to 13.30 hrs Lunch Session VI Chairpersons * Dr. R. K. Goyal, Vice Chancellor, M. S. University, India * Dr. Matthias H. Tschöp, Associate Professor, Departments of Psychiatry and Medicine, Obesity Research Centre/Genome Research Institute, University of Cincinnati, College of Medicine, USA 13.30 - 14.15 hr Invited Lecture (IL-7) Dr. Ho Cho Vice President, Ambrx, USA 14.15 - 15.00 hr Keynote address “Beyond Small Molecules: The Use of Biologics in the Treatment of Metabolic Disorders” Dr. Richard DiMarchi Linda & Jack Gill Chair in Biomolecular Sciences and Professor of Chemistry, Indiana University Retired Group Vice President, Eli Lilly & Company, USA 15.00 - 15.30 hr Oral Presentation - I ( 15 mins) Oral Presentation - II ( 15 mins) 15.30 to 16.15 hrs Panel discussion Chairperson: Dr. Charles Burant, Dr. Robert C. and Veronica Atkins Professor of Metabolism, University of Michigan, USA Dr. Richard DiMarchi Linda & Jack Gill Chair in Biomolecular Sciences and Professor of Chemistry, Indiana University Retired Group Vice President, Eli Lilly & Company, USA Dr. Suad Efendic Professor, Karolinska Institutet, Sweden Dr. Per-Olof Berggren The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Sweden Dr. R. K. Goyal Vice Chancellor, MS University, Baroda, India Dr. Jean Whaley Director, Diabetes Drug Discovery, Bristol-Myers Squibb, USA Dr. Ho Cho Vice President, Ambrx, USA 16.30 - 17.00 hr Closing Remarks Pankaj Patel, Chairman & Managing Director, Zydus Cadila Zydus Research Centre Sarkhej-Bavla NH#8A, Moraiya, Ahmedabad-382210 Phone: +91-02717-250801 Fax: +91-02717-250606 Contact Person E-mails Dr. Mukul Jain [email protected] Dr. Abhijit Chatterjee [email protected] Mr. Ankit Saxena [email protected] Ms. Clarine [email protected] Mr. Nazir Patel [email protected] http://www.rbfsymposium.net/